Page last updated: 2024-11-04

temozolomide and Hemoglobinuria, Paroxysmal

temozolomide has been researched along with Hemoglobinuria, Paroxysmal in 1 studies

Hemoglobinuria, Paroxysmal: A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.

Research Excerpts

ExcerptRelevanceReference
"Temozolomide (TMZ) is, in combination with radiotherapy (RT), the treatment of choice for glioblastoma multiforme."3.83Persistent bone marrow depression following short-term treatment with temozolomide. ( Brandal, P; Johannesen, TB; Tjønnfjord, GE; Vandraas, K, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vandraas, K1
Tjønnfjord, GE1
Johannesen, TB1
Brandal, P1

Other Studies

1 other study available for temozolomide and Hemoglobinuria, Paroxysmal

ArticleYear
Persistent bone marrow depression following short-term treatment with temozolomide.
    BMJ case reports, 2016, Apr-29, Volume: 2016

    Topics: Aged; Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Brain Neoplasms; Dacarb

2016